109 Combined Modality Conference: "Peptide Receptor Radionuclide Therapy (PRRT)" (030719)"NOT ACCREDITED"
The combined modality therapy approach, including the medical, surgical and radiation arms of cancer therapy, provides
the best treatment options for the management of a wide variety of cancer patients with complex problems. This course is
designed to educate an audience specializing in the care of cancer patients. This conference provides a forum for
multimodality interaction that promotes discussion of the most recent clinical research affecting patient care, as well as
bringing oncology specialists together to review cases and make recommendations for managing cancer patients.
Medical Radiation, and Surgical Oncologists; Radiologists; Pathologists; Urologists; Neurologists; UTSW Faculty, Fellows
and Residents in training; and private practice oncologists
At the conclusion of this activity, participants should be able to:
- Review the management of a diversified group of cancer patients through case presentations with pathologic and radiologic review and discussions by medical, radiation and surgical oncologists
- Distinguish the importance of the interaction of surgical, medical and radiation modalities in the treatment of these patients
- Present the most recent advances in cancer therapy and basic cancer research from a clinical and laboratory perspective, with an emphasis on new translational research approaches.
- 1.00 AMA
- 1.00 Attendance